{"id":"https://openalex.org/W2180657199","doi":"https://doi.org/10.1007/978-0-387-76643-0_13","title":"Analysis of Irreversible Aggregation, Reversible Self-association and Fragmentation of Monoclonal Antibodies by Analytical Ultracentrifugation","display_name":"Analysis of Irreversible Aggregation, Reversible Self-association and Fragmentation of Monoclonal Antibodies by Analytical Ultracentrifugation","publication_year":2009,"publication_date":"2009-10-10","ids":{"openalex":"https://openalex.org/W2180657199","doi":"https://doi.org/10.1007/978-0-387-76643-0_13","mag":"2180657199"},"language":"en","primary_location":{"id":"doi:10.1007/978-0-387-76643-0_13","doi":"https://doi.org/10.1007/978-0-387-76643-0_13","is_oa":false,"landing_page_url":"https://doi.org/10.1007/978-0-387-76643-0_13","pdf_url":null,"source":{"id":"https://openalex.org/S4306463937","display_name":"Springer eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Trends in Monoclonal Antibody Development and Manufacturing","raw_type":"book-chapter"},"volume":{"id":"https://openalex.org/W640298501","display_name":"Current Trends in Monoclonal Antibody Development and Manufacturing"},"type":"book-chapter","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000961644","display_name":"James D. Andya","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James D. Andya","raw_affiliation_strings":["Early Stage Pharmaceutical Development, Genentech, Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Early Stage Pharmaceutical Development, Genentech, Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100361885","display_name":"Jun Liu","orcid":"https://orcid.org/0000-0002-5815-2483","observed_orcids":["https://orcid.org/0000-0002-5815-2483","https://orcid.org/0000-0002-7394-8172"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jun Liu","raw_affiliation_strings":["Late Stage Pharmaceutical and Processing Development, Genentech, Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Late Stage Pharmaceutical and Processing Development, Genentech, Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110296609","display_name":"Steven J. Shire","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Steven J. Shire","raw_affiliation_strings":["Late Stage Pharmaceutical and Processing Development, Genentech, Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Late Stage Pharmaceutical and Processing Development, Genentech, Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5110296609"],"corresponding_institution_ids":["https://openalex.org/I183934855"],"apc_list":null,"apc_paid":null,"fwci":1.1685,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.78556502,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":95},"biblio":{"volume":null,"issue":null,"first_page":"207","last_page":"227"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":1.0},{"id":"https://openalex.org/keywords/protein-aggregation","display_name":"protein aggregation","score":0.984000027179718},{"id":"https://openalex.org/keywords/irreversible-aggregation","display_name":"irreversible aggregation","score":0.8899999856948853},{"id":"https://openalex.org/keywords/fragmentation","display_name":"fragmentation","score":0.6859999895095825},{"id":"https://openalex.org/keywords/protein-degradation","display_name":"protein degradation","score":0.8040000200271606},{"id":"https://openalex.org/keywords/protein-stability","display_name":"protein stability","score":0.6359999775886536},{"id":"https://openalex.org/keywords/protein-pharmaceuticals","display_name":"pharmaceutical proteins","score":0.609000027179718},{"id":"https://openalex.org/keywords/analytical-ultracentrifugation","display_name":"analytical ultracentrifugation","score":0.7459999918937683}],"concepts":[{"id":"https://openalex.org/C2910425616","wikidata":"https://www.wikidata.org/wiki/Q85741465","display_name":"Analytical Ultracentrifugation","level":3,"score":0.9150768518447876},{"id":"https://openalex.org/C54689828","wikidata":"https://www.wikidata.org/wiki/Q2029259","display_name":"Ultracentrifuge","level":2,"score":0.7561450004577637},{"id":"https://openalex.org/C191015642","wikidata":"https://www.wikidata.org/wiki/Q1132459","display_name":"Fragmentation (computing)","level":2,"score":0.7292027473449707},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.6511081457138062},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5620225071907043},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.40694624185562134},{"id":"https://openalex.org/C12554922","wikidata":"https://www.wikidata.org/wiki/Q7100","display_name":"Biophysics","level":1,"score":0.3402032256126404},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.31732505559921265},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.19215431809425354},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.18267685174942017},{"id":"https://openalex.org/C18903297","wikidata":"https://www.wikidata.org/wiki/Q7150","display_name":"Ecology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1007/978-0-387-76643-0_13","doi":"https://doi.org/10.1007/978-0-387-76643-0_13","is_oa":false,"landing_page_url":"https://doi.org/10.1007/978-0-387-76643-0_13","pdf_url":null,"source":{"id":"https://openalex.org/S4306463937","display_name":"Springer eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Trends in Monoclonal Antibody Development and Manufacturing","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.5683000087738037}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":34,"referenced_works":["https://openalex.org/W80211724","https://openalex.org/W163080191","https://openalex.org/W597159688","https://openalex.org/W1532634227","https://openalex.org/W1597166471","https://openalex.org/W1968154997","https://openalex.org/W1973570145","https://openalex.org/W1975317507","https://openalex.org/W1975639729","https://openalex.org/W1975985041","https://openalex.org/W1985440252","https://openalex.org/W2015060415","https://openalex.org/W2015082998","https://openalex.org/W2025687917","https://openalex.org/W2036378400","https://openalex.org/W2042139529","https://openalex.org/W2052288218","https://openalex.org/W2060907660","https://openalex.org/W2061187228","https://openalex.org/W2063820553","https://openalex.org/W2079210436","https://openalex.org/W2100801974","https://openalex.org/W2131535785","https://openalex.org/W2146653841","https://openalex.org/W2150766477","https://openalex.org/W2157143879","https://openalex.org/W2170864258","https://openalex.org/W2239709951","https://openalex.org/W2316323923","https://openalex.org/W2329751713","https://openalex.org/W2343891719","https://openalex.org/W2494378574","https://openalex.org/W4251265903","https://openalex.org/W4252256883"],"related_works":["https://openalex.org/W4396890367","https://openalex.org/W2409870026","https://openalex.org/W788465070","https://openalex.org/W2995462719","https://openalex.org/W1942688422","https://openalex.org/W2504733729","https://openalex.org/W2028489320","https://openalex.org/W2589121320","https://openalex.org/W2596798204","https://openalex.org/W2421809921"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2016-06-24T00:00:00"}